Jean-Paul van Basten MD. PhD.

Jean-Paul van Basten is urologist at the Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands. Dr. van Basten is an instructor of laparoscopic and robotic surgery , and official proctor in robotic surgery in the Netherlands. He is the chairman of the working group on Dutch Recommendations in Laparoscopic and Robotic Surgery in Urology.

Van Basten is an ambassador for the Santeon hospital alliance value-based healthcare (VHBC) project concerning prostate cancer. He is also a co-investigator in the Movember-trial concerning global comparison of treatment outcomes of prostate cancer. Van Basten is head of the urology department, and member of the medical board of the Canisius Wilhelmina hospital.

Specialism: Urology


JPA van Basten received his M.D. in 1996 at the University of Maastricht, and during his studies he did research on typhoid perforation at the University hospitals in Sumatra (Rumah Sakit Universitas Sumatera Utara, Medan) and Ghana (Komfo Anokye Teaching Hospital, Komasi). In 1999, he defended his thesis entitled ‘The sexual  sequelae of testicular cancer’ at the University of Groningen. The subject was quality of life, with special focus on sexuality of young testicular cancer survivors.

Following his residency in general surgery at the University Hospital in Maastricht, he was recruited to urology in 1999 at the University Hospital of Groningen. In 2003, he started a fellowship in minimally invasive oncological urology at the Radboud University Medical Center, the Netherlands. Further to that  he spent  two weeks in New York, visiting Memorial Sloan Kettering Cancer Center, and did a mini-fellowship in robotic surgery at the University of Los Angeles. Dr. van Basten is a member of several scientific societies including the European Association of Urology and is  a board member of the Dutch Society of Endo-Urology, and faculty member of the International GU-OncoForum.

He is editor-in-chief of the books: Dutch recommendations in Laparoscopy in Urology and Recommendations in Laparoscopic and Robotic Surgery in Urology, which forms the theoretical basis of the exam in laparoscopic skills for Dutch residents in urology. Furthermore, he is editor of the Dutch Journal of Oncology.

On 25th October 2014, he performed the first radical prostatectomy in the Netherlands with the Xi Da Vinci robotic platform.

The Canisius Wilhelmina Hospital is one of the seven large teaching hospitals collaborating within the Santeon alliance. The Santeon hospitals collaborate in improving the quality of care of prostate cancer patients, via data analysis, prospective acquisition of medical data and patient reported outcome measurements (PROMS). The latter is in close collaboration with The International Consortium for Health Outcomes Measurement (ICHOM). On behalf of the Santeon hospitals, van Basten participated as an ICHOM member in the development of ICHOM outcome standards set for advanced prostate cancer.